Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Journal of Experimental Medicine Année : 2012

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

Yannis Duffourd
  • Fonction : Auteur
  • PersonId : 994654
Qiang Wen
  • Fonction : Auteur
Daniel Gautheret
  • Fonction : Auteur
  • PersonId : 833936
Isabelle Radford
  • Fonction : Auteur
William Vainchenker
Philippe Dessen
  • Fonction : Auteur
  • PersonId : 940894
John Crispino
  • Fonction : Auteur
Olivier Bernard

Résumé

Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease generally associated with poor prognosis. Gene expression profiles indicate the existence of distinct molecular subgroups, and several genetic alterations have been characterized in the past years, including the t(1;22)(p13;q13) and the trisomy 21 associated with GATA1 mutations. However, the majority of patients do not present with known mutations, and the limited access to primary patient leukemic cells impedes the efficient development of novel therapeutic strategies. In this study, using a xenotransplantation approach, we have modeled human pediatric AMKL in immunodeficient mice. Analysis of high-throughput RNA sequencing identified recurrent fusion genes defining new molecular subgroups. One subgroup of patients presented with MLL or NUP98 fusion genes leading to up-regulation of the HOX A cluster genes. A novel CBFA2T3-GLIS2 fusion gene resulting from a cryptic inversion of chromosome 16 was identified in another subgroup of 31% of non-Down syndrome AMKL and strongly associated with a gene expression signature of Hedgehog pathway activation. These molecular data provide useful markers for the diagnosis and follow up of patients. Finally, we show that AMKL xenograft models constitute a relevant in vivo preclinical screening platform to validate the efficacy of novel therapies such as Aurora A kinase inhibitors.
Fichier principal
Vignette du fichier
Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.pdf (3.61 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02353632 , version 1 (06-05-2020)

Identifiants

Citer

Clarisse Thiollier, Cécile Lopez, Bastien Gerby, Cathy Ignacimouttou, Sandrine Poglio, et al.. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models. Journal of Experimental Medicine, 2012, 209 (11), pp.2017-2031. ⟨10.1084/jem.20121343⟩. ⟨hal-02353632⟩
70 Consultations
54 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More